CTRI/2013/03/003488已完成3 期
To study the safety and efficacy of use of Mifepristone along with Misoprostol for medical termination of pregnancy in second trimester (12-20weeks)
Dr Pushpa Junghare0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Women wanting to undergo second trimester medical termination of pregnancy (12-20weeks)
排除标准
- •Known hypersensitivity to Mifepristone or Misoprostol
- •Women with medical renal disease,liver disease
- •Women with heart disease
- •Hb less than 8gm%
研究者
相似试验
进行中（未招募）
不适用
A Randomised Controlled Trial on Efficacy of mifepristone followed by 6-8 hours versus 24 hours vaginal misoprostol in Early Pregnancy Abortions (< 63 days gestations) - TIMES studyMedical termination of pregnancies before nine weeks of pregnancyEUCTR2009-010277-21-GBCalthorpe Clinic
已完成
不适用
Comparing efficacy of vaginal misoprostol administered at 6-8 hours with 24 hours administration after 200 mg of oral mifepristone for early medical abortionsISRCTN97410750Calthorpe Clinic (UK)1,200
招募中
3 期
Investigating the efficacy and safety of Umifenovir in controlling the symptoms of patients with COVID-19IRCT20080901001165N46Center for Progress and Development of Iran200
招募中
2 期
To compare Oral Mifepristone with Foley catheter for softening of cervix in women planned for delivery at or after 39 weeks of pregnancyCTRI/2021/07/034943JIPMER INTRAMURA
已完成
3 期
mifenovir effectiveness in the treatment of COVID-19IRCT20200322046833N1Center for Progress and Development of Iran100